​Development of engineered IgM antibodies
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2024 | IGM BIOSCIENCES, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination (No Activity) |
— | $10,000 | |
| 2024 | IGM BIOSCIENCES, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $50,000 | |
| 2024 | IGM BIOSCIENCES, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $80,000 | |
| 2024 | IGM BIOSCIENCES, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $110,000 | |
| 2023 | IGM BIOSCIENCES, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $240,000 | |
| 2023 | IGM BIOSCIENCES, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $230,000 | |
| 2023 | IGM BIOSCIENCES, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $230,000 | |
| 2023 | IGM BIOSCIENCES, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $230,000 | |
| 2022 | IGM BIOSCIENCES, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $210,000 | |
| 2022 | IGM BIOSCIENCES, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $190,000 |
| Client | Filings | Total Income |
|---|---|---|
| IGM BIOSCIENCES, INC. | 14 | — |
| Name | Disclosed Prior Position |
|---|---|
| ANDREW WESLEY WOMACK |